We further validated the association between PRKDC expression and the basal-like PAM50 subtype using data obtained from a contemporary collection of primary breast cancer tissues from women enrolled in the SCAN-B trial40 (NCT02306096) (Fig. 6d). Here, PRKDC is linked to breast carcinoma.